Skip to main content
Erschienen in: Endocrine 3/2018

10.01.2018 | Original Article

Effects of short-term DHEA intake on hormonal responses in young recreationally trained athletes: modulation by gender

verfasst von: Katia Collomp, Corinne Buisson, Nicolas Gravisse, Soraya Belgherbi, Zakaria Labsy, Manh-Cuong Do, Olivier Gagey, Sophie Dufay, Nancy Vibarel-Rebot, Michel Audran

Erschienen in: Endocrine | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Dehydroepiandrosterone (DHEA) figures on the World Anti-Doping Agency list of prohibited substances in sport because it is assumed that athletes expect a significant increase in testosterone through DHEA administration. The literature on the hormonal effects of DHEA intake nevertheless appears to be very scant in healthy young subjects, especially women.

Purpose

We examined the effects of DHEA on adrenal and gonadal hormones, IGF1 and free T3 in healthy young male and female recreationally trained volunteers.

Methods

The study followed a double-blind, randomized-order crossover design. Lean healthy young men (n = 10) and women (n = 11), with all women using oral contraceptives, were treated daily with 100 mg of DHEA and placebo for 4 weeks. DHEA, DHEA-sulfate (DHEA-S), androstenedione, total testosterone (Tes), dihydrotestosterone (DHT), SHBG, estrone, cortisol, IGF1, and free T3 were measured before, in the middle and at the end of each treatment, as were blood glucose, liver transaminases and lipid status.

Results

We observed a significant increase in DHEA, DHEA-S, androstenedione, Tes, DHT, and estrone in both men and women in the middle and at the end of DHEA treatment, but the increase in Tes was more marked in women (p < 0.001) than men (p < 0.05). No changes were found in the other parameters, irrespective of gender.

Conclusion

In young athletes, DHEA administration induces significant blood hormonal changes, some modulated by gender, which can be used as biomarkers of doping.
Literatur
2.
Zurück zum Zitat E. Barrett-Connor, Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus. Ann. Intern. Med. 117, 807–811 (1992)CrossRef E. Barrett-Connor, Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus. Ann. Intern. Med. 117, 807–811 (1992)CrossRef
3.
Zurück zum Zitat P.D. Kroboth, F.S. Salek, A.L. Pittenger, T.J. Fabian, R.F. Frye, DHEA and DHEA-S: a review. J. Clin. Pharmacol. 39, 327–348 (1999)CrossRef P.D. Kroboth, F.S. Salek, A.L. Pittenger, T.J. Fabian, R.F. Frye, DHEA and DHEA-S: a review. J. Clin. Pharmacol. 39, 327–348 (1999)CrossRef
4.
Zurück zum Zitat C. Ohlsson, F. Labrie, E. Barrett-Connor, M.K. Karlsson, O. Ljunggren, L. Vandenput, D. Mellström, A. Tivesten, Low serum levels of dehydroepiandrosterone sulfate predict all-cause and cardiovascular mortality in elderly Swedish men. J. Clin. Endocrinol. Metab. 95, 4406–4414 (2010)CrossRef C. Ohlsson, F. Labrie, E. Barrett-Connor, M.K. Karlsson, O. Ljunggren, L. Vandenput, D. Mellström, A. Tivesten, Low serum levels of dehydroepiandrosterone sulfate predict all-cause and cardiovascular mortality in elderly Swedish men. J. Clin. Endocrinol. Metab. 95, 4406–4414 (2010)CrossRef
5.
Zurück zum Zitat A.M. Traish, H.P. Kang, F. Saad, A.T. Guay, Dehydroepiandrosterone (DHEA) a precursor steroid or an active hormone in human physiology. J. Sex. Med. 8, 2960–2982 (2011)CrossRef A.M. Traish, H.P. Kang, F. Saad, A.T. Guay, Dehydroepiandrosterone (DHEA) a precursor steroid or an active hormone in human physiology. J. Sex. Med. 8, 2960–2982 (2011)CrossRef
6.
Zurück zum Zitat M.C. Jimenez, Q. Sun, M. Schürks, S. Chiuve, F.B. Hu, J.E. Manson, K.M. Rexrode, Low dehydroepiandrosterone sulfate is associated with increased risk of ischemic stroke among women. Stroke 44, 1784–1789 (2013)CrossRef M.C. Jimenez, Q. Sun, M. Schürks, S. Chiuve, F.B. Hu, J.E. Manson, K.M. Rexrode, Low dehydroepiandrosterone sulfate is associated with increased risk of ischemic stroke among women. Stroke 44, 1784–1789 (2013)CrossRef
7.
Zurück zum Zitat A. Caufriez, R. Leproult, M. L’Hermite-Balériaux, M. Kerkhofs, G. Copinschi, Effects of a 3-week dehydroepiandrosterone administration on sleep, sex steroids and multiple 24-h hormonal profiles in postmenopausal women: a pilot study. Clin. Endocrinol. 79, 716–724 (2013) A. Caufriez, R. Leproult, M. L’Hermite-Balériaux, M. Kerkhofs, G. Copinschi, Effects of a 3-week dehydroepiandrosterone administration on sleep, sex steroids and multiple 24-h hormonal profiles in postmenopausal women: a pilot study. Clin. Endocrinol. 79, 716–724 (2013)
8.
Zurück zum Zitat A.M. Kenny, R.S. Boxer, A. Kleppinger, J. Brindisi, R. Feinn, J.A. Burleson, Dehydroepiandrosterone combined with exercise improves muscle strength and physical function in frail older women. J. Am. Geriatr. Soc. 58, 1707–1714 (2010)CrossRef A.M. Kenny, R.S. Boxer, A. Kleppinger, J. Brindisi, R. Feinn, J.A. Burleson, Dehydroepiandrosterone combined with exercise improves muscle strength and physical function in frail older women. J. Am. Geriatr. Soc. 58, 1707–1714 (2010)CrossRef
9.
Zurück zum Zitat P. Merritt, B. Stangl, E. Hirshman, J. Verbalis, Administration of dehydroepiandrosterone (DHEA) increases serum levels of androgens and estrogens but does not enhance short-term memory in post-menopausal women. Brain Res. 5(1483), 54–62 (2012)CrossRef P. Merritt, B. Stangl, E. Hirshman, J. Verbalis, Administration of dehydroepiandrosterone (DHEA) increases serum levels of androgens and estrogens but does not enhance short-term memory in post-menopausal women. Brain Res. 5(1483), 54–62 (2012)CrossRef
10.
Zurück zum Zitat A.J. Morales, J.J. Nolan, J.C. Nelson, S.S. Yen, Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. Endocrinol. Metab. 78, 1360–1367 (1994)PubMed A.J. Morales, J.J. Nolan, J.C. Nelson, S.S. Yen, Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. Endocrinol. Metab. 78, 1360–1367 (1994)PubMed
11.
Zurück zum Zitat A.J. Morales, R.H. Haubrich, J.Y. Hwang, H. Asakura, S.S. Yen, The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin. Endocrinol. 49, 421–432 (1998)CrossRef A.J. Morales, R.H. Haubrich, J.Y. Hwang, H. Asakura, S.S. Yen, The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin. Endocrinol. 49, 421–432 (1998)CrossRef
12.
Zurück zum Zitat S. Rubino, M. Stomati, C. Bersi, E. Casarosa, M. Luisi, F. Petraglia, A.R. Genazzani, Neuroendocrine effect of a short-term treatment with DHEA in postmenopausal women. Maturitas 28, 251–257 (1998)CrossRef S. Rubino, M. Stomati, C. Bersi, E. Casarosa, M. Luisi, F. Petraglia, A.R. Genazzani, Neuroendocrine effect of a short-term treatment with DHEA in postmenopausal women. Maturitas 28, 251–257 (1998)CrossRef
13.
Zurück zum Zitat B. Stangl, E. Hirshman, J. Verbalis, Administration of dehydroepiandrosterone (DHEA) enhances visual-spatial performance in postmenopausal women. Behav. Neurosci. 125, 742–752 (2011)CrossRef B. Stangl, E. Hirshman, J. Verbalis, Administration of dehydroepiandrosterone (DHEA) enhances visual-spatial performance in postmenopausal women. Behav. Neurosci. 125, 742–752 (2011)CrossRef
14.
Zurück zum Zitat D. Von Mühlen, G.A. Laughlin, D. Kritz-Silverstein, J. Bergstrom, R. Bettencourt, Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial. Osteoporos. Int. 19, 699–707 (2008)CrossRef D. Von Mühlen, G.A. Laughlin, D. Kritz-Silverstein, J. Bergstrom, R. Bettencourt, Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial. Osteoporos. Int. 19, 699–707 (2008)CrossRef
15.
Zurück zum Zitat S. Yamada, M. Akishita, S. Fukai, S. Ogawa, K. Yamaguchi, J. Matsuyama, K. Kozaki, K. Toba, Y. Ouchi, Effects of dehydroepiandrosterone supplementation on cognitive function and activities of daily living in older women with mild to moderate cognitive impairment. Geriatr. Gerontol. Int. 10, 280–287 (2010)CrossRef S. Yamada, M. Akishita, S. Fukai, S. Ogawa, K. Yamaguchi, J. Matsuyama, K. Kozaki, K. Toba, Y. Ouchi, Effects of dehydroepiandrosterone supplementation on cognitive function and activities of daily living in older women with mild to moderate cognitive impairment. Geriatr. Gerontol. Int. 10, 280–287 (2010)CrossRef
16.
Zurück zum Zitat K.T. Barnhart, E. Freeman, J.A. Grisso, D.J. Rader, M. Sammel, S. Kapoor, J.E. Nestler, The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J. Clin. Endocrinol. Metab. 84, 3896–3902 (1999)PubMed K.T. Barnhart, E. Freeman, J.A. Grisso, D.J. Rader, M. Sammel, S. Kapoor, J.E. Nestler, The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J. Clin. Endocrinol. Metab. 84, 3896–3902 (1999)PubMed
17.
Zurück zum Zitat M.B. Wallace, J. Lim, A. Cutler, L. Bucci, Effects of dehydroepiandrosterone vs androstenedione supplementation in men. Med. Sci. Sports Exerc. 31, 1788–1792 (1999)CrossRef M.B. Wallace, J. Lim, A. Cutler, L. Bucci, Effects of dehydroepiandrosterone vs androstenedione supplementation in men. Med. Sci. Sports Exerc. 31, 1788–1792 (1999)CrossRef
18.
Zurück zum Zitat T.C. Liu, C.H. Lin, C.Y. Huang, J.L. Ivy, C.H. Kuo, Effect of acute DHEA administration on free testosterone in middle-aged and young men following high-intensity interval training. Eur. J. Appl. Physiol. 113, 1783–1792 (2013)CrossRef T.C. Liu, C.H. Lin, C.Y. Huang, J.L. Ivy, C.H. Kuo, Effect of acute DHEA administration on free testosterone in middle-aged and young men following high-intensity interval training. Eur. J. Appl. Physiol. 113, 1783–1792 (2013)CrossRef
19.
Zurück zum Zitat P.D. Kroboth, J.A. Amico, R.A. Stone, M. Folan, R.F. Frye, F.J. Kroboth, K.L. Bigos, T.J. Fabian, A.M. Linares, B.G. Pollock, C. Hakala, Influence of DHEA administration on 24-hour cortisol concentrations. J. Clin. Psychopharmacol. 23, 96–99 (2003)CrossRef P.D. Kroboth, J.A. Amico, R.A. Stone, M. Folan, R.F. Frye, F.J. Kroboth, K.L. Bigos, T.J. Fabian, A.M. Linares, B.G. Pollock, C. Hakala, Influence of DHEA administration on 24-hour cortisol concentrations. J. Clin. Psychopharmacol. 23, 96–99 (2003)CrossRef
20.
Zurück zum Zitat J.E. Nestler, C.O. Barlascini, J.N. Clore, W.G. Blackard, Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J. Clin. Endocrinol. Metab. 66, 57–61 (1988)CrossRef J.E. Nestler, C.O. Barlascini, J.N. Clore, W.G. Blackard, Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J. Clin. Endocrinol. Metab. 66, 57–61 (1988)CrossRef
21.
Zurück zum Zitat G.A. Brown, M.D. Vukovich, R.L. Sharp, T.A. Reifenrath, K.A. Parsons, D.S. King, Effect of oral DHEA on serum testosterone and adaptations to resistance training in young men. J. Appl. Physiol. 1999(87), 2274–2283 (1985) G.A. Brown, M.D. Vukovich, R.L. Sharp, T.A. Reifenrath, K.A. Parsons, D.S. King, Effect of oral DHEA on serum testosterone and adaptations to resistance training in young men. J. Appl. Physiol. 1999(87), 2274–2283 (1985)
22.
Zurück zum Zitat Y.H. Liao, K.F. Liao, C.L. Kao, C.Y. Chen, C.Y. Huang, W.H. Chang, J.L. Ivy, J.R. Bernard, S.D. Lee, C.H. Kuo, Effect of dehydroepiandrosterone administration on recovery from mix-type exercise training-induced muscle damage. Eur. J. Appl. Physiol. 113, 99–107 (2013)CrossRef Y.H. Liao, K.F. Liao, C.L. Kao, C.Y. Chen, C.Y. Huang, W.H. Chang, J.L. Ivy, J.R. Bernard, S.D. Lee, C.H. Kuo, Effect of dehydroepiandrosterone administration on recovery from mix-type exercise training-induced muscle damage. Eur. J. Appl. Physiol. 113, 99–107 (2013)CrossRef
23.
Zurück zum Zitat S.M. Ostojic, J. Calleja, M. Jourkesh, Effects of short-term dehydroepiandrosterone supplementation on body composition in young athletes. Chin. J. Physiol. 53, 19–25 (2010)CrossRef S.M. Ostojic, J. Calleja, M. Jourkesh, Effects of short-term dehydroepiandrosterone supplementation on body composition in young athletes. Chin. J. Physiol. 53, 19–25 (2010)CrossRef
24.
Zurück zum Zitat F. González, C.L. Sia, D.M. Bearson, H.E. Blair, Hyperandrogenism induces a proinflammatory TNFα response to glucose ingestion in a receptor-dependent fashion. J. Clin. Endocrinol. Metab. 99, E848–E854 (2014)CrossRef F. González, C.L. Sia, D.M. Bearson, H.E. Blair, Hyperandrogenism induces a proinflammatory TNFα response to glucose ingestion in a receptor-dependent fashion. J. Clin. Endocrinol. Metab. 99, E848–E854 (2014)CrossRef
25.
Zurück zum Zitat H.J. Coelingh Bennink, Y. Zimmerman, E. Laan, H.M. Termeer, N. Appels, A. Albert, B.C. Fauser, J.H. Thijssen, R.H. van Lunsen, Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects. Contraception 96, 322–329 (2017)CrossRef H.J. Coelingh Bennink, Y. Zimmerman, E. Laan, H.M. Termeer, N. Appels, A. Albert, B.C. Fauser, J.H. Thijssen, R.H. van Lunsen, Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects. Contraception 96, 322–329 (2017)CrossRef
26.
Zurück zum Zitat S.G. Beckham, C.P. Earnest, Four weeks of androstenedione supplementation diminishes the treatment response in middle aged men. Br. J. Sports Med. 37, 212–218 (2003)CrossRef S.G. Beckham, C.P. Earnest, Four weeks of androstenedione supplementation diminishes the treatment response in middle aged men. Br. J. Sports Med. 37, 212–218 (2003)CrossRef
27.
Zurück zum Zitat S. Welle, R. Jozefowicz, M. Statt, Failure of dehydroepiandrosterone to influence energy and protein metabolism in humans. J. Clin. Endocrinol. Metab. 71, 1259–1264 (1990)CrossRef S. Welle, R. Jozefowicz, M. Statt, Failure of dehydroepiandrosterone to influence energy and protein metabolism in humans. J. Clin. Endocrinol. Metab. 71, 1259–1264 (1990)CrossRef
28.
Zurück zum Zitat K.S. Nair, R.A. Rizza, P. O’Brien, K. Dhatariya, K.R. Short, A. Nehra, J.L. Vittone, G.G. Klee, A. Basu, R. Basu, C. Cobelli, G. Toffolo, C. Dalla Man, D.J. Tindall, L.J. Melton 3rd, G.E. Smith, S. Khosla, M.D. Jensen, DHEA in elderly women and DHEA or testosterone in elderly men. N. Engl. J. Med. 355, 1647–1659 (2006)CrossRef K.S. Nair, R.A. Rizza, P. O’Brien, K. Dhatariya, K.R. Short, A. Nehra, J.L. Vittone, G.G. Klee, A. Basu, R. Basu, C. Cobelli, G. Toffolo, C. Dalla Man, D.J. Tindall, L.J. Melton 3rd, G.E. Smith, S. Khosla, M.D. Jensen, DHEA in elderly women and DHEA or testosterone in elderly men. N. Engl. J. Med. 355, 1647–1659 (2006)CrossRef
29.
Zurück zum Zitat R.S. Boxer, A. Kleppinger, J. Brindisi, R. Feinn, J.A. Burleson, A.M. Kenny, Effects of dehydroepiandrosterone (DHEA) on cardiovascular risk factors in older women with frailty characteristics. Age Ageing 39, 451–458 (2010)CrossRef R.S. Boxer, A. Kleppinger, J. Brindisi, R. Feinn, J.A. Burleson, A.M. Kenny, Effects of dehydroepiandrosterone (DHEA) on cardiovascular risk factors in older women with frailty characteristics. Age Ageing 39, 451–458 (2010)CrossRef
30.
Zurück zum Zitat M. Srinivasan, B.A. Irving, R.L. Frye, P. O’Brien, S.J. Hartman, J.P. McConnell, K.S. Nair, Effects on lipoprotein particles of long-term dehydroepiandrosterone in elderly men and women and testosterone in elderly men. J. Clin. Endocrinol. Metab. 95, 1617–1625 (2010)CrossRef M. Srinivasan, B.A. Irving, R.L. Frye, P. O’Brien, S.J. Hartman, J.P. McConnell, K.S. Nair, Effects on lipoprotein particles of long-term dehydroepiandrosterone in elderly men and women and testosterone in elderly men. J. Clin. Endocrinol. Metab. 95, 1617–1625 (2010)CrossRef
31.
Zurück zum Zitat M.L. Kohut, J.R. Thompson, J. Campbell, G.A. Brown, M.D. Vukovich, D.A. Jackson, D.S. King, Ingestion of a dietary supplement containing dehydroepiandrosterone (DHEA) and androstenedione has minimal effect on immune function in middle-aged men. J. Am. Coll. Nutr. 22, 363–371 (2003)CrossRef M.L. Kohut, J.R. Thompson, J. Campbell, G.A. Brown, M.D. Vukovich, D.A. Jackson, D.S. King, Ingestion of a dietary supplement containing dehydroepiandrosterone (DHEA) and androstenedione has minimal effect on immune function in middle-aged men. J. Am. Coll. Nutr. 22, 363–371 (2003)CrossRef
32.
Zurück zum Zitat A. Igwebuike, B.A. Irving, M.L. Bigelow, K.R. Short, J.P. McConnell, K.S. Nair, Lack of dehydroepiandrosterone effect on a combined endurance and resistance exercise program in postmenopausal women. J. Clin. Endocrinol. Metab. 93, 534–538 (2008)CrossRef A. Igwebuike, B.A. Irving, M.L. Bigelow, K.R. Short, J.P. McConnell, K.S. Nair, Lack of dehydroepiandrosterone effect on a combined endurance and resistance exercise program in postmenopausal women. J. Clin. Endocrinol. Metab. 93, 534–538 (2008)CrossRef
33.
Zurück zum Zitat T. Elraiyah, M.B. Sonbol, Z. Wang, T. Khairalseed, N. Asi, C. Undavalli, M. Nabhan, O. Altayar, L. Prokop, V.M. Montori, M.H. Murad, Clinical review: The benefits and harms of systemic dehydroepiandrosterone (DHEA) in postmenopausal women with normal adrenal function: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 99, 3536–3542 (2014)CrossRef T. Elraiyah, M.B. Sonbol, Z. Wang, T. Khairalseed, N. Asi, C. Undavalli, M. Nabhan, O. Altayar, L. Prokop, V.M. Montori, M.H. Murad, Clinical review: The benefits and harms of systemic dehydroepiandrosterone (DHEA) in postmenopausal women with normal adrenal function: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 99, 3536–3542 (2014)CrossRef
34.
Zurück zum Zitat K.K. Dhatariya, L.J. Greenlund, M.L. Bigelow, P. Thapa, A.L. Oberg, G.C. Ford, J.M. Schimke, K.S. Nair, Dehydroepiandrosterone replacement therapy in hypoadrenal women: protein anabolism and skeletal muscle function. Mayo. Clin. Proc. 83, 1218–1225 (2008)CrossRef K.K. Dhatariya, L.J. Greenlund, M.L. Bigelow, P. Thapa, A.L. Oberg, G.C. Ford, J.M. Schimke, K.S. Nair, Dehydroepiandrosterone replacement therapy in hypoadrenal women: protein anabolism and skeletal muscle function. Mayo. Clin. Proc. 83, 1218–1225 (2008)CrossRef
35.
Zurück zum Zitat G. Gebre-Medhin, E.S. Husebye, H. Mallmin, L. Helström, C. Berne, F.A. Karlsson, O. Kämpe, Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison’s disease. Clin. Endocrinol. 52, 775–780 (2000)CrossRef G. Gebre-Medhin, E.S. Husebye, H. Mallmin, L. Helström, C. Berne, F.A. Karlsson, O. Kämpe, Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison’s disease. Clin. Endocrinol. 52, 775–780 (2000)CrossRef
36.
Zurück zum Zitat J.J. Christiansen, N.H. Andersen, K.E. Sørensen, E.M. Pedersen, P. Bennett, M. Andersen, J.S. Christiansen, J.O. Jørgensen, C.H. Gravholt, Dehydroepiandrosterone substitution in female adrenal failure: no impact on endothelial function and cardiovascular parameters despite normalization of androgen status. Clin. Endocrinol. 66, 426–433 (2007)CrossRef J.J. Christiansen, N.H. Andersen, K.E. Sørensen, E.M. Pedersen, P. Bennett, M. Andersen, J.S. Christiansen, J.O. Jørgensen, C.H. Gravholt, Dehydroepiandrosterone substitution in female adrenal failure: no impact on endothelial function and cardiovascular parameters despite normalization of androgen status. Clin. Endocrinol. 66, 426–433 (2007)CrossRef
37.
Zurück zum Zitat T. Yeung, J. Chai, R. Li, V. Lee, P.C. Ho, E. Ng, A double-blind randomised controlled trial on the effect of dehydroepiandrosterone on ovarian reserve markers, ovarian response and number of oocytes in anticipated normal ovarian responders. BJOG 123, 1097–1105 (2016)CrossRef T. Yeung, J. Chai, R. Li, V. Lee, P.C. Ho, E. Ng, A double-blind randomised controlled trial on the effect of dehydroepiandrosterone on ovarian reserve markers, ovarian response and number of oocytes in anticipated normal ovarian responders. BJOG 123, 1097–1105 (2016)CrossRef
38.
Zurück zum Zitat G. Corona, G. Rastrelli, V.A. Giagulli, A. Sila, A. Sforza, G. Forti, E. Mannucci, M. Maggi, Dehydroepiandrosterone supplementation in elderly men: a meta-analysis study of placebo-controlled trials. J. Clin. Endocrinol. Metab. 98, 3615–3626 (2013)CrossRef G. Corona, G. Rastrelli, V.A. Giagulli, A. Sila, A. Sforza, G. Forti, E. Mannucci, M. Maggi, Dehydroepiandrosterone supplementation in elderly men: a meta-analysis study of placebo-controlled trials. J. Clin. Endocrinol. Metab. 98, 3615–3626 (2013)CrossRef
39.
Zurück zum Zitat F. Labrie, DHEA, important source of sex steroids in men and even more in women. Prog. Brain Res. 182, 97–148 (2010)CrossRef F. Labrie, DHEA, important source of sex steroids in men and even more in women. Prog. Brain Res. 182, 97–148 (2010)CrossRef
40.
Zurück zum Zitat WADA, Technical document reporting and evaluation guidance for testosterone, epitestosterone, T/E ratio and other endogenous steroids: TD2016EAAS, World Anti-Doping Agency (WADA), Montreal (2016). WADA, Technical document reporting and evaluation guidance for testosterone, epitestosterone, T/E ratio and other endogenous steroids: TD2016EAAS, World Anti-Doping Agency (WADA), Montreal (2016).
41.
Zurück zum Zitat M. Schönfelder, H. Hofmann, T. Schulz, T. Engl, D. Kemper, B. Mayr, C. Rautenberg, R. Oberhoffer, D. Thieme, Potential detection of low-dose transdermal testosterone administration in blood, urine, and saliva. Drug. Test. Anal. 8, 1186–1196 (2016)CrossRef M. Schönfelder, H. Hofmann, T. Schulz, T. Engl, D. Kemper, B. Mayr, C. Rautenberg, R. Oberhoffer, D. Thieme, Potential detection of low-dose transdermal testosterone administration in blood, urine, and saliva. Drug. Test. Anal. 8, 1186–1196 (2016)CrossRef
42.
Zurück zum Zitat H. Lund, A.H. Snilsberg, T.G. Halvorsen, P. Hemmersbach, L. Reubsaet, Comparison of newly developed immuno-MS method with existing DELFIA(®) immunoassay for human chorionic gonadotropin determination in doping analysis. Bioanalysis 5, 623–630 (2013)CrossRef H. Lund, A.H. Snilsberg, T.G. Halvorsen, P. Hemmersbach, L. Reubsaet, Comparison of newly developed immuno-MS method with existing DELFIA(®) immunoassay for human chorionic gonadotropin determination in doping analysis. Bioanalysis 5, 623–630 (2013)CrossRef
43.
Zurück zum Zitat M. Okano, Y. Nishitani, M. Sato, S. Kageyama, Effectiveness of GH isoform differential immunoassay for detecting rhGH doping on application of various growth factors. Drug Test. Anal. 4, 692–700 (2012).CrossRef M. Okano, Y. Nishitani, M. Sato, S. Kageyama, Effectiveness of GH isoform differential immunoassay for detecting rhGH doping on application of various growth factors. Drug Test. Anal. 4, 692–700 (2012).CrossRef
44.
Zurück zum Zitat S.C. Voss, N. Robinson, M. Alsayrafi, P.C. Bourdon, Y.O. Schumacher, M. Saugy, S. Giraud, The effect of a period of intense exercise on the marker approach to detect growth hormone doping in sports. Drug. Test. Anal. 6, 582–586 (2014)CrossRef S.C. Voss, N. Robinson, M. Alsayrafi, P.C. Bourdon, Y.O. Schumacher, M. Saugy, S. Giraud, The effect of a period of intense exercise on the marker approach to detect growth hormone doping in sports. Drug. Test. Anal. 6, 582–586 (2014)CrossRef
45.
Zurück zum Zitat P. Fénichel, F. Paris, P. Philibert, S. Hiéronimus, L. Gaspari, J.Y. Kurzenne, P. Chevallier, S. Bermon, N. Chevalier, C. Sultan, Molecular diagnosis of 5α-reductase deficiency in 4 elite young female athletes through hormonal screening for hyperandrogenism. J. Clin. Endocrinol. Metab. 98, E1055–E1059 (2013)CrossRef P. Fénichel, F. Paris, P. Philibert, S. Hiéronimus, L. Gaspari, J.Y. Kurzenne, P. Chevallier, S. Bermon, N. Chevalier, C. Sultan, Molecular diagnosis of 5α-reductase deficiency in 4 elite young female athletes through hormonal screening for hyperandrogenism. J. Clin. Endocrinol. Metab. 98, E1055–E1059 (2013)CrossRef
46.
Zurück zum Zitat S. Bermon, P.Y. Garnier, A.L. Hirschberg, N. Robinson, S. Giraud, R. Nicoli, N. Baume, M. Saugy, P. Fénichel, S.J. Bruce, H. Henry, G. Dollé, M. Ritzen, Serum androgen levels in elite female athletes. J. Clin. Endocrinol. Metab. 99, 4328–4335 (2014)CrossRef S. Bermon, P.Y. Garnier, A.L. Hirschberg, N. Robinson, S. Giraud, R. Nicoli, N. Baume, M. Saugy, P. Fénichel, S.J. Bruce, H. Henry, G. Dollé, M. Ritzen, Serum androgen levels in elite female athletes. J. Clin. Endocrinol. Metab. 99, 4328–4335 (2014)CrossRef
47.
Zurück zum Zitat F. Ponzetto, F. Mehl, J. Boccard, N. Baume, S. Rudaz, M. Saugy, R. Nicoli, Longitudinal monitoring of endogenous steroids in human serum by UHPLC-MS/MS as a tool to detect testosterone abuse in sports. Anal. Bioanal. Chem. 408, 705–719 (2016)CrossRef F. Ponzetto, F. Mehl, J. Boccard, N. Baume, S. Rudaz, M. Saugy, R. Nicoli, Longitudinal monitoring of endogenous steroids in human serum by UHPLC-MS/MS as a tool to detect testosterone abuse in sports. Anal. Bioanal. Chem. 408, 705–719 (2016)CrossRef
Metadaten
Titel
Effects of short-term DHEA intake on hormonal responses in young recreationally trained athletes: modulation by gender
verfasst von
Katia Collomp
Corinne Buisson
Nicolas Gravisse
Soraya Belgherbi
Zakaria Labsy
Manh-Cuong Do
Olivier Gagey
Sophie Dufay
Nancy Vibarel-Rebot
Michel Audran
Publikationsdatum
10.01.2018
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2018
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-017-1514-z

Weitere Artikel der Ausgabe 3/2018

Endocrine 3/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.